---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-124047"
form_type: "8-K"
ticker: "BDSX"
cik: "0001439725"
company_name: "BIODESIX INC"
filed_at: "2025-05-21T23:59:59+00:00"
generated_at: "2026-05-20T22:23:27.950939+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Biodesix shareholders approve reverse stock split ratio range 1:2 to 1:20

## Summary
- Shareholders approved reverse stock split of common stock at ratio between 1-for-2 and 1-for-20, as determined by board.
- KPMG LLP ratified as independent auditor for FY 2025 with 124.9M votes for.
- ESPP amended: shares available increased by 1.45M; annual automatic increase cap raised to 3.0M.
- Lawrence T. Kennedy Jr. and Matthew Strobeck elected as Class II directors at annual meeting.

## SEC filing metadata
- accession: 0001193125-25-124047
- form_type: 8-K
- ticker: BDSX
- cik: 0001439725
- company_name: BIODESIX INC
- filed_at: 2025-05-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1439725/000119312525124047/0001193125-25-124047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1439725/000119312525124047/d19624d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-124047
- JSON: https://secwatch.observer/filing/0001193125-25-124047.json
- Plain text: https://secwatch.observer/filing/0001193125-25-124047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.